BioSpace News Archive

Business

TRANSPLANT GENOMICS WELCOMES CHIEF MEDICAL OFFICER JON FRIEDMAN, MD, FAST

Dr. Friedman brings 30 years of success in delivering value for patients, healthcare providers, and payors to help Transplant Genomics deliver on its mission.

February 1, 2022

·

2 min read

Pharm Country

Janssen Data at ASCO GU Demonstrate Longstanding Leadership in Prostate Cancer and Commitment to Advancing Potential New Therapeutic Options for Genitourinary Cancers

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that 17 presentations will be featured at the 2022 American Society of Clinical Oncology Genitourinary Cancers Symposium, taking place in San Francisco and virtually from February 17-19.

February 1, 2022

·

14 min read

Pharm Country

Jasper Health Raises $25 Million in Series A Funding to Increase Access to Comprehensive Cancer Experience and Care Navigation Platform

Jasper Health today announced a $25 million Series A funding round led by General Catalyst.

February 1, 2022

·

4 min read

Biotech Bay

New Data Show Statistically Significant Reduction in Chronic Cancer-Related Lymphedema with Early Detection Using ImpediMed’s L-Dex® Technology and Intervention

ImpediMed Limited announced publication of results from the PREVENT trial showing that fewer breast cancer patients with early detection using L-Dex and intervention progressed to chronic lymphedema when compared to patients monitored with tape measure, which is the current standard of care.

February 1, 2022

·

7 min read

BioMidwest

AtriCure to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

AtriCure, Inc., a leading innovator in surgical treatments for atrial fibrillation and left atrial appendage management, announced that the company will be participating in the upcoming 11th Annual SVB Leerink Global Healthcare Conference.

February 1, 2022

·

1 min read

Business

Seagen Appoints Lee Heeson as Executive Vice President, Commercial International

Seagen Inc. (Nasdaq:SGEN) today announced the appointment of Lee Heeson as Executive Vice President, Commercial International.

February 1, 2022

·

3 min read

Genetown

Fractyl Health Publishes Two-Year Durability Data After a Single Revita DMR® Therapeutic Procedure in Patients with Type 2 Diabetes

Fractyl Health, an organ-editing metabolic therapeutics company focused on pioneering a new approach to the treatment of type 2 diabetes, announced the publication of two-year durability data from its REVITA-1 clinical study conducted at centers in Europe and South America.

February 1, 2022

·

6 min read

Business

Cortexyme Announces Pipeline Update and Anticipated 2022 Milestones

Cortexyme, Inc. today provided a business update and announced key milestones for 2022.

February 1, 2022

·

9 min read

Pharm Country

Halberd Achieves Landmark Selective Elimination of Tau From an Antigen Mixture

Halberd Corporation (OTC PINK:HALB) has demonstrated the ability to selectively reduce and control the level of one element in a heterogeneous mixture containing two elements without affecting the levels of the second element.

February 1, 2022

·

3 min read

Bio NC

Biofidelity Raises $23M in Series A+ Financing led by Octopus Ventures to Launch ASPYRE Technology

Biofidelity, a pioneer in precision cancer diagnostics, has successfully completed a heavily oversubscribed $23 million Series A+ investment round, led by Octopus Ventures and backed by SBI Investment Co. Ltd. and existing investors.

February 1, 2022

·

3 min read